The first Phase 3 data for a cancer vaccine has raised questions about whether the potential new treatment is needed.

Traders making bullish bets on chip stocks are getting walloped this month, as renewed fears emerged about investment returns ...

Oil has climbed back to an Iran-war high and may soon go higher, if the U.S. and Israel strike Iran after their respective ...

How to change your approach as the stock-market seesaws, some good news for home buyers, and advice from The Moneyist.

A company beating earnings expectations by 36% and revenue expectations by 15% would usually see a post-results bump. But not ...

Investors favored flashier AI plays earlier this year, but some analysts say Nvidia’s dependability could now hold more ...

Dear Dollar Signs, I cannot seem to get out of credit-card debt no matter what I do. It’s not a lot — about $4,500 — but it’s ...

An unyielding U.S. economy has shrugged off a number of blows to keep growing at a faster-than-expected speed — and there’s a ...

As she faces a tough midterm race, the five-term GOP senator is touting her successful lobbying effort against certain ...

If market pressures keep building, Anthropic “could reasonably decide it is better to stay private and wait for a better opportunity,” one portfolio manager says.

Store aisles are getting a digital makeover.

A surprisingly strong U.S. economy sustained its vigor on the verge of the holiday shopping season, a pair of S&P surveys ...